[{"address1": "Ole MaalOees Vej 3", "address2": "Copenhagen N", "city": "Copenhagen", "zip": "2200", "country": "Denmark", "phone": "45 70 70 29 80", "website": "https://www.iobiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers. In addition, the company develops IO170, a TGF\u00df1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark.", "fullTimeEmployees": 79, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mai-Britt  Zocca Ph.D.", "age": 56, "title": "Founder, President, CEO, Principal Financial Officer & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 908461, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy B. Sullivan M.B.A.", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 650708, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Qasim Iftikhar Ahmad M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 709800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Inge Marie Svane M.D., Ph.D.", "title": "Founder & Clinical Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Mads Hald Andersen M.D., Ph.D.", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Anders  Ljungqvist", "title": "Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Per Thor Straten", "title": "Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Faulkner M.B.A.", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Devin Whittemore Smith J.D.", "age": 56, "title": "Secretary, General Counsel & Chief Compliance Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 621800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel G. Mannix Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.93, "open": 1.97, "dayLow": 1.91, "dayHigh": 2.08, "regularMarketPreviousClose": 1.93, "regularMarketOpen": 1.97, "regularMarketDayLow": 1.91, "regularMarketDayHigh": 2.08, "payoutRatio": 0.0, "beta": 0.36, "forwardPE": -1.7606838, "volume": 399906, "regularMarketVolume": 399906, "averageVolume": 241530, "averageVolume10days": 617270, "averageDailyVolume10Day": 617270, "bid": 2.02, "ask": 2.09, "bidSize": 1, "askSize": 1, "marketCap": 135714656, "fiftyTwoWeekLow": 0.66, "fiftyTwoWeekHigh": 2.24, "fiftyDayAverage": 1.4624, "twoHundredDayAverage": 1.089095, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 100391680, "profitMargins": 0.0, "floatShares": 31282893, "sharesOutstanding": 65880900, "sharesShort": 384241, "sharesShortPriorMonth": 139277, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0058, "heldPercentInsiders": 0.00358, "heldPercentInstitutions": 0.66427004, "shortRatio": 1.63, "shortPercentOfFloat": 0.012200001, "impliedSharesOutstanding": 65880900, "bookValue": 0.401, "priceToBook": 5.137157, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -98455000, "trailingEps": -1.49, "forwardEps": -1.17, "enterpriseToEbitda": -1.032, "52WeekChange": 0.560606, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 2.06, "targetHighPrice": 14.0, "targetLowPrice": 6.0, "targetMeanPrice": 9.5, "targetMedianPrice": 9.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 37086000, "totalCashPerShare": 0.563, "ebitda": -97312000, "totalDebt": 1763000, "quickRatio": 2.079, "currentRatio": 2.316, "debtToEquity": 6.672, "returnOnAssets": -0.70131, "returnOnEquity": -1.38778, "freeCashflow": -45581500, "operatingCashflow": -80486000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IOBT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "IO Biotech, Inc.", "corporateActions": [], "postMarketTime": 1753484557, "regularMarketTime": 1753473601, "longName": "IO Biotech, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": 6.73575, "regularMarketPrice": 2.06, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1636119000000, "postMarketChangePercent": 1.9417458, "postMarketPrice": 2.1, "postMarketChange": 0.03999996, "regularMarketChange": 0.13, "regularMarketDayRange": "1.91 - 2.08", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 241530, "fiftyTwoWeekLowChange": 1.3999999, "fiftyTwoWeekLowChangePercent": 2.1212118, "fiftyTwoWeekRange": "0.66 - 2.24", "fiftyTwoWeekHighChange": -0.18000007, "fiftyTwoWeekHighChangePercent": -0.08035717, "fiftyTwoWeekChangePercent": 56.0606, "earningsTimestamp": 1747224300, "earningsTimestampStart": 1747224300, "earningsTimestampEnd": 1747224300, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.49, "epsForward": -1.17, "epsCurrentYear": -1.14, "priceEpsCurrentYear": -1.8070176, "exchange": "NMS", "messageBoardId": "finmb_1685354464", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": 0.5976, "fiftyDayAverageChangePercent": 0.40864334, "twoHundredDayAverageChange": 0.97090495, "twoHundredDayAverageChangePercent": 0.89147866, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-05", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "displayName": "IO Biotech", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]